With CancerIQ's complete telehealth cancer-risk platform you can virtually screen for cancer predisposition, identify high-risk patients through testing and genetic counseling, and manage their care.
Cancer doesn't stop for COVID-19. Patient safety is vital and early detection is the best way to combat cancer, improve patient outcomes and reduce the cost of care. Converting programs virtually via telehealth is the way forward to keep early detection going strong.
-2.png)
Engage patients with the CancerIQ Screening Toolkit, a short and easy digital questionnaire that can be completed anywhere and allows patient capture of detailed family history and immediately flags patients for counseling, testing and MRI eligibility.
Facilitate comprehensive virtual programs with the CancerIQ Specialist and Manager. It features a robust GC workflow with pedigree, order-guidance for appropriate genetic testing, auto-creation of medical necessity forms for payers, and digital patient engagement to drive subsequent visits and treatment adherence.
Patients can complete a short digital questionnaire in the comfort of their own home on their own device.
Keep a continued focus on patient safety and on improving patient outcomes and quality of life with early detection and treatment.
Utilize the latest NCCN and USPSTF guidelines and Tyrer-Cuzick to identify patients eligible for counseling, testing or MRI.
To not disturb workflow, CancerIQ automatically calculates risk results in digital form so you can communicate patient risk in real-time.
To improve patient uptake of genetic services, CancerIQ has features to collect patient interest and record appointment availability right at the point of care.
Lab orders are electronically sent to testing labs of your choice, with results received back into CancerIQ and the EHR. Our lab partnerships enable the direct drop-shipment of test kits to patients' homes, eliminating the need for in-person visits.
Data entered by the patient from home is immediately available in a clean registry. Staff can easily edit information and update the patient's risk score if appropriate.
Start sending customized emails to patients based on their risk factors and response status. Supplement email outreach by using CancerIQ to manage phone call lists and mass mailers.
Engage and educate patients remotely with our robust online pedigree tool.
Volume for the AHEAD Program was down 40% one month into COVID-19. Adventist launched their telehealth program with CancerIQ and are now at over 80% volume in the clinic, with more clinic visits returning and utilizing virtual genetic consults. Fridays are now dedicated 100% to virtual genetic consults and they are averaging an additional 10-15 consults a week (pre-test) that will continue to rise in another month as they consult for post-genetic test results.
The Adventist Health Early All-Around Detection program includes a team of physicians who are specialists in gynecology, internal medicine, urology, oncology/hematology, dermatology and breast and reconstruction surgery who have a shared goal of helping patients in early detection and interventions. This may include increased surveillance and effective treatment plans that will reduce risk of cancer.
High-risk patients need those preventative services and our ability to pick up breast cancer at an early stage. I am so excited to be able to take Hereditary Cancer Risk assessment, genetic counseling and testing to our patients - safely from comforts of their homes!
Candace Westgate, DO, OB-GYN and founder of the AHEAD Program at Adventist Health - St. Helena
515 N. State, Suite 1025 Chicago, IL 60654
Phone: 312-761-3360
Email: info@cancer-iq.com
